/Companies

Cognito Therapeutics

Cambridge, US · Incorporated in Cayman Islands · 1 known investors

Find your way into Cognito Therapeutics

Sign up to see every warm intro you have to Cognito Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Cognito Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

BVBrent Vaughan
Brent VaughanExecutiveBrent Vaughan is an executive officer and director at Cognito Therapeutics who previously held roles at Lilly, Roche, Novartis, and Nektar, where he worked on drug development and commercialization across CNS, cardiometabolic, and oncology indications. He holds patents in AI/ML and optogenetics applications for CNS diagnosis and treatment.

Board

HLHelen Liang
Helen LiangBoard directorFounder & General Partner at FoundersX Ventures
SB
Stephen BrusoBoard director
JH
Jeffrey HalisBoard director
GC
Gerald ChanBoard director
RK
Richard KuntzBoard director
LB
Laura BregeBoard director

Investors · 1

Funding

SEC filings, press & company announcements

$224M disclosed across 3 of 4 rounds · 2022–2026

▶$10.2MraisedJul 2024 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Brent VaughanExecutive Officer, Director
  • Helen LiangDirector
  • Stephen BrusoDirector
  • Jeffrey HalisDirector
  • Gerald ChanDirector
  • Richard KuntzDirector
  • Laura BregeDirector
Offering amount
$60M
Amount sold
$10.2M
First sale
Jun 2024
Incorporated
Other, Cayman Islands
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$108.8MraisedNov 2023 · 13 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Brent VaughanExecutive Officer, Director
  • Gerald ChanDirector
  • Helen LiangDirector
  • Stephen BrusoDirector
  • Richard KuntzDirector
Offering amount
$126.2M
Amount sold
$108.8M
First sale
Jun 2022
Incorporated
Other, Cayman Islands
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Cognito Therapeutics went on to found or lead other companies.

Frequently asked questions

Who are Cognito Therapeutics's investors?
Cognito Therapeutics's investors include FoundersX Ventures.
How much funding has Cognito Therapeutics raised?
Cognito Therapeutics has disclosed $224M raised across 3 of its 4 known rounds.
Where is Cognito Therapeutics headquartered?
Cognito Therapeutics is headquartered in Cambridge, US.